Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ming Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Paclitaxel, Liposomes, Cisplatin, Receptors, Estrogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Jilin Province, Jilin Province Development and Reform Commission.
Abstract (Originalsprache)
Ovarian malignancies overexpress estrogen receptors (ERs), offering a therapeutic avenue for targeted drug delivery. Here, we developed a novel ER-targeted PEGylated liposome (ES-SSL-PTX/CDDP) coencapsulating paclitaxel (PTX) and cisplatin (CDDP) to enhance therapeutic efficacy and mitigate systemic toxicity. ES-SSL-PTX/CDDP exhibited a spherical shape with a hydrodynamic diameter of around 150 nm, a negative zeta potential of about -20 mV, and high encapsulation efficiencies of 83.7% for PTX and 41.1% for CDDP. ES-SSL-PTX/CDDP showed a sustained release pattern, with release rates of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
- Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun 130061, China.
ORCID-Profile: Jin Pei
Förderung
- Department of Science and Technology of Jilin Province
- Jilin Province Development and Reform Commission
Zitieren
APA
Zhu, M., Jia, J., Tang, H., Xie, Y., Lv, Z., Bao, H., Zhang, Y., Miao, D., Guo, X., Chen, K., Wang, S., Yu, L., & Pei, J. (2025). Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01457
Vancouver
Zhu M, Jia J, Tang H, Xie Y, Lv Z, Bao H, et al. Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01457
BibTeX
@article{Zhu2025,
author = {Zhu, Ming and Jia, Juan and Tang, Huan and Xie, Yizhuo and Lv, Zhe and Bao, Han and Zhang, Yan and Miao, Dongfanghui and Guo, Xin and Chen, Kejia and Wang, Shanshan and Yu, Liangping and Pei, Jin},
title = {Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01457}
}
EUVIMED